# Leadership Vision — Healthcare AI Platform

**Author:** Girish Rajeev  
**Role:** Senior Director, AI & Clinical Data Platforms  
**Experience:** 25+ years pharma/biotech AI | Former Takeda Alta Petens ($125M) | CDISC CORE Board

---

## Executive Vision

This platform represents my vision for how a world-class healthcare AI team should be built, led, and scaled. It is grounded in 25+ years of leading applied AI programmes in regulated healthcare environments — including leading Alta Petens, Takeda's $125M enterprise AI transformation scaling 100+ global team members across drug discovery, clinical, regulatory, manufacturing, and commercial functions.

The principles here are not theoretical. They reflect hard-won lessons from building Klinixa (real-time trial matching), deploying single-cell sequencing AI at scale, and delivering enterprise GenAI tools that passed FDA, EMA, and PMDA audit readiness reviews.

---

## Team Architecture
### Organisational Structure

```
VP / Senior Director, Healthcare AI
|
|-- Applied Science Lead (GenAI / LLM / RAG)
|   |-- 2x Senior Applied Scientists -- LLM engineering, RAG pipelines
|   +-- 1x ML Engineer -- model serving, MLOps
|
|-- Clinical AI Lead (Domain + Modelling)
|   |-- 2x Clinical Data Scientists -- FHIR, clinical standards, validation
|   +-- 1x Biostatistician -- clinical trial AI, survival models
|
|-- Medical Imaging Lead (CV / Radiomics)
|   |-- 2x Computer Vision Engineers -- segmentation, classification
|   +-- 1x Radiomics Scientist -- CT/MRI feature extraction
|
|-- Platform Engineering Lead
|   |-- 2x ML Engineers -- FastAPI, Docker, CI/CD, model registry
|   +-- 1x Data Engineer -- FHIR ingestion, feature store, pipelines
|
+-- AI Governance & Compliance Lead
    |-- 1x AI Ethics / Fairness Analyst
    +-- 1x Regulatory Affairs Specialist -- FDA SaMD, HIPAA
```
### Hiring Philosophy

**Hire for domain depth first, ML breadth second.** In healthcare AI, a candidate who deeply understands clinical workflows, regulatory constraints, and patient safety will always outperform a pure ML engineer who does not. The best healthcare AI teams combine both.

**Senior IC profile I hire:** 5+ years healthcare/pharma, hands-on Python or SAS, demonstrated ability to work with clinicians and regulators, not just engineers. Ideally has shipped something into a production clinical environment.

**What I look for beyond the CV:**
- Can they explain a clinical concept to an engineer AND explain a model to a clinician?
- Have they ever had to defend a model decision to a regulator?
- Do they think about failure modes before deployment?

---

## OKRs — Year 1

### Q1 — Foundation (Months 1–3)
**Objective: Establish technical foundation and governance before scaling**

| Key Result | Target | Measurement |
|-----------|--------|-------------|
| RAG pipeline deployed over FHIR R4 patient records | 10,000 patient records indexed | Vector store query latency < 2s |
| AI governance framework live | 100% of AI decisions audit-logged | Zero PHI in LLM prompts |
| Clinical safety thresholds defined | All models have recall > 0.75 gate | Deployment checklist 100% complete |
| Team hired to 60% headcount | 6 of 10 roles filled | Offer acceptance rate > 80% |

### Q2 — First Products (Months 4–6)
**Objective: Ship two AI-powered clinical features to production**

| Key Result | Target | Measurement |
|-----------|--------|-------------|
| Clinical documentation copilot in pilot | 3 pilot sites, 50 clinicians | Documentation time reduced 40% |
| Drug safety screening API live | 100% of new prescriptions screened | Zero missed MAJOR interactions in audit |
| Therapist-patient matching v1 deployed | Match acceptance rate > 75% | 90-day retention improvement |
| MLflow model registry operational | All models versioned and tracked | Zero untracked production models |

### Q3 — Scale (Months 7–9)
**Objective: Prove ROI and prepare for enterprise rollout**

| Key Result | Target | Measurement |
|-----------|--------|-------------|
| Documented AI ROI across 3 pilots | Net positive ROI demonstrated | Finance sign-off on ROI report |
| Fairness audit completed on all models | Zero demographic disparity > 10% | Bias audit report published internally |
| Model serving handles 10x load | 99.9% uptime SLA met | Load test results documented |
| AI literacy programme launched | 50% of clinical staff at Level 1 | Training completion tracking |

### Q4 — Expand (Months 10–12)
**Objective: Institutionalise AI as a core capability**

| Key Result | Target | Measurement |
|-----------|--------|-------------|
| AI Centre of Excellence formally established | CoE charter approved by leadership | Cross-functional membership confirmed |
| 5 production AI features live | All passing clinical safety thresholds | Monthly model performance reviews |
| Enterprise AI roadmap approved | Board-level presentation delivered | 3-year roadmap signed off |
| Team at full headcount | 10 of 10 roles filled | Attrition < 10% in year 1 |

---

## Operating Model

### Decision Framework

I use a three-tier decision model for healthcare AI:

**Tier 1 — Build vs Buy vs Partner**
- Build: Core differentiated IP (matching algorithms, clinical models, proprietary data pipelines)
- Buy: Commodity infrastructure (vector stores, monitoring, CI/CD)
- Partner: Regulated components requiring vendor BAA (LLM APIs, cloud HIPAA environments)

**Tier 2 — Pilot Sequencing**
Each AI initiative must answer three questions before receiving engineering resources:
1. What is the measurable clinical or business outcome?
2. What is the minimum viable dataset to validate the hypothesis?
3. What is the regulatory pathway if this becomes a medical device (FDA SaMD)?

**Tier 3 — Ship vs Hold**
No model goes to production without passing:
- Clinical safety gate (recall ≥ 0.75 for high-acuity use cases)
- Fairness audit (≤ 10% disparity across protected groups)
- Responsible AI checklist (12 items — see `src/governance/ai_governance.py`)
- Human oversight definition (who reviews, who can override, what triggers escalation)

### Stakeholder Management

**Engineering:** Weekly technical review. I stay close to architecture decisions — not to code review PRs, but to ensure we are not building technical debt that will fail a regulatory audit in 18 months.

**Clinical / Medical Affairs:** Bi-weekly clinical validation review. Every AI output that touches a patient decision has a clinician champion who can defend it.

**Legal / Compliance / Regulatory Affairs:** Monthly governance review. AI governance report shared at this cadence. No surprises at audit time.

**Product:** Joint roadmap planning quarterly. AI capabilities must map to product milestones — not exist as standalone science projects.

**Executive / Board:** Quarterly AI scorecard. ROI, adoption, incidents, and roadmap progress in a single one-page view.

---

## Talent Development

### Career Ladders for Applied Scientists in Healthcare AI

One of the most common failures I see in healthcare AI teams is unclear career progression for applied scientists — they either drift toward pure research or get absorbed into engineering. I maintain a dual ladder:

**Individual Contributor Track:**
- Applied Scientist I → II → Senior → Staff → Principal
- Promotion criteria: technical depth, clinical impact, cross-functional influence, publications/patents

**Management Track:**
- Senior Applied Scientist → Tech Lead → Manager → Senior Manager → Director
- Promotion criteria: team performance, hiring quality, stakeholder trust, business outcomes

### What I invest in for team development:
- **Conference budget** — each team member presents at one industry conference per year (AMIA, HIMSS, NeurIPS Health, ICLR)
- **Clinical immersion** — every AI engineer spends 1 day per quarter shadowing a clinician in their use case area
- **Regulatory literacy** — all team members complete FDA AI/ML SaMD training in their first 90 days
- **Publication and IP** — I actively encourage and support publications and patent filings for novel clinical AI methods

---

## Responsible AI in Healthcare — My Non-Negotiables

After 25+ years in regulated healthcare AI, these are the principles I will not compromise on:

**1. Human in the loop for high-stakes decisions**
AI assists clinicians — it never replaces clinical judgment for diagnosis, treatment, or patient safety decisions. Period.

**2. Fairness is not optional**
Every model is audited for performance parity across race, gender, age, language, and insurance type before deployment. A model that performs well on average but poorly for a specific demographic group does not go to production.

**3. Explainability is a clinical requirement**
If a clinician cannot understand why the model made a recommendation, the model is not ready for clinical use. Attention maps, SHAP values, and rule-based fallbacks are built in from the start — not retrofitted.

**4. Privacy by design**
PHI is de-identified before any LLM call. No exceptions. No "we'll fix it later." This is a HIPAA violation waiting to happen and I have zero tolerance for it.

**5. Audit trail is immutable**
Every AI-assisted clinical decision is logged with a tamper-evident hash. When the regulator asks "show me every decision this model made in the last 12 months," the answer is ready in 24 hours.

**6. Crisis always escalates to a human**
For mental health, suicide risk, and any acute safety concern — hard-coded escalation to a human clinician. No AI model handles a crisis autonomously. Ever.

---

## What Success Looks Like in Year 2

By the end of year 2, a high-performing healthcare AI team under my leadership will have:

- **3–5 production AI features** embedded in core clinical and operational workflows
- **Measurable ROI** documented and presented to the board (target: 3x return on AI investment)
- **Zero regulatory incidents** — no PHI breaches, no biased model deployments, no audit failures
- **Industry recognition** — at least one published paper, one conference presentation, one industry award nomination
- **A team that wants to stay** — attrition below 10%, internal promotions happening, team members being recruited by other companies (and choosing to stay)
- **A platform others build on** — internal teams requesting access to the AI platform to power their own products

---

## Reference Implementation

The code in this repository (`healthcare-ai-agents`) is a reference implementation of this vision — demonstrating the technical architecture, governance framework, and AI strategy that underpins this leadership approach.

Key files:
- `STRATEGY.md` — Enterprise AI transformation roadmap
- `src/governance/ai_governance.py` — Responsible AI framework implementation
- `src/recommender/therapist_matcher.py` — Precision matching engine
- `src/agents/clinical_agent.py` — Multi-agent clinical decision support
- `src/rag/clinical_rag.py` — Clinical RAG pipeline over FHIR R4

---

*This document reflects my personal leadership philosophy developed over 25+ years of leading applied AI teams in regulated healthcare environments.*

*Girish Rajeev — linkedin.com/in/girish-rajeev-756808138*
